mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
temsirolimus |
FIMM |
pan-cancer |
AAC |
0.53 |
0.0003 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.0009 |